PRALUENT Trademark

Trademark Overview

On Tuesday, June 24, 2014, a trademark application was filed for PRALUENT with the United States Patent and Trademark Office. The USPTO has given the PRALUENT trademark a serial number of 86318389. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, March 10, 2021. This trademark is owned by Sanofi. The PRALUENT trademark is filed in the Pharmaceutical Products category with the following description:

Cardiovascular pharmaceuticals
praluent

General Information

Serial Number86318389
Word MarkPRALUENT
Filing DateTuesday, June 24, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, March 10, 2021
Registration Number4659691
Registration DateTuesday, December 23, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2014

Trademark Statements

Goods and ServicesCardiovascular pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 1, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameREGENERON PHARMACEUTICALS, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTARRYTOWN, NY 10591
Party NameSANOFI BIOTECHNOLOGY
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
Address75008 PARIS
FR
Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Trademark Events

Event DateEvent Description
Saturday, December 23, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 10, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, March 10, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, February 22, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 17, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, April 15, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 19, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 23, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, October 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 4, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 2, 2014ASSIGNED TO LIE
Thursday, August 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 20, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 19, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 19, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 1, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 1, 2014NON-FINAL ACTION E-MAILED
Friday, August 1, 2014NON-FINAL ACTION WRITTEN
Friday, August 1, 2014ASSIGNED TO EXAMINER
Tuesday, July 1, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 27, 2014NEW APPLICATION ENTERED

Related Keywords

praluent pharmaceuticals cardiovascular